Takeda Pharmaceutical
303 hedge funds and large institutions have $1.06B invested in Takeda Pharmaceutical in 2025 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 112 increasing their positions, 90 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
303
Holders Change
+8
Holders Change %
+2.71%
% of All Funds
4.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
55
Increased
112
Reduced
90
Closed
36
Calls
$25.9M
Puts
$646K
Net Calls
+$25.3M
Net Calls Change
+$2.87M
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$51M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$12.5M |
| 3 |
Goldman Sachs
New York
|
+$10.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.12M |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$6.91M |
Top Sellers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$41.9M |
| 2 |
Millennium Management
New York
|
-$26.1M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$15.6M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$7.43M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$7.21M |
